Richard E. Uihlein - 17 Sep 2021 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director, 10%+ Owner
Signature
/s/ Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
17 Sep 2021
Net transactions value
+$11,574,070,000,000
Form type
4
Filing time
21 Sep 2021, 16:30:15 UTC
Next filing
25 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GALT Convertible Note Award $11,574,070,000,000 +1,157,407 +13% $10000000.00* 10,000,000 17 Sep 2021 Common Stock 1,157,407 $8.64 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes interest that may accrue following issuance of the Note.
F2 The Note is convertible upon 60 days prior written notice by the noteholder.
F3 In consideration for the Convertible Note, the Reporting Person loaned ten million dollars to the Company.
F4 Represents the principal amount of the note payable.